Skip to content

    Recently Viewed

      Listening...

      Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.

      Innovative Medicine

      Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

      MedTech

      Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.

      Solving the toughest health challenges

      Innovation
      Close-up of a woman with low vision receiving an eye exam exam with a doctor shining light into her left eye

      What to know about low vision

      Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. For Low Vision Awareness Month, learn the facts—plus, the promising treatment innovations that are in the works.
      Innovation
      A female scientist conducting research in a laboratory, focusing on orphan drugs for rare diseases

      What is an orphan drug?

      The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.

      Do you know what heart failure is? (Hint: It’s probably not what you think)

      For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
      Innovation
      Scientist examining a sample in a petri dish

      Could we be on our way to eliminating cancer for good?

      What once seemed like an out-of-reach goal may soon be within our grasp. Take an in-depth look at how Johnson & Johnson is working toward its vision of helping create a world without cancer.
      Innovation
      Two surgeons in full PPE viewing their patient's heart on a monitor in preparation for surgery

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Innovation
      scientist-looking-through-microscope

      How Johnson & Johnson is advancing new options for bladder cancer treatment

      Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
      Health & wellness
      An illustration of a crowd of people, all in black and white, with one person in the center wearing a red top and blue pants.

      What is a rare disease?

      It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.
      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Innovation
      A doctor holding a catheter for AFib

      5 things we now know about atrial fibrillation

      More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For American Heart Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.
      Innovation
      Anatomy of the human spine and back

      An eye for innovation: helping surgeons see more during spinal operations

      With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
      Health & wellness
      A man and a boy getting haircuts at a barber shop

      “As black men, we keep things close to the hip": 5 questions for a urologist about prostate cancer

      The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. For Black History Month, we spoke with a physician about building awareness and normalizing tough conversations.
      Health & wellness
      A close-up of someone with green and yellow blood pressure cuffs on their legs

      5 things we now know about peripheral artery disease

      The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
      Latest News
      A black female scientist in goggles viewing yellow liquid in a beaker

      Johnson & Johnson named a 2024 Fortune World’s Most Admired Company

      The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Innovation
      Brain scans may catch Alzheimer's disease before it starts

      Could we be on the cusp of catching Alzheimer’s before it starts?

      The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.